Found 90 matching trials
A Bioequivalence Study of Two Different Processes of PEG-rhGH Preparations PHASE1 The purpose of this study is to investigate whether PEG-rhGH with new prepa...
Show More Location
Chengdu Xinhua Hospital
Learn More & Join Trial
Thymalfasin-based PRaG Mode for Advanced Refractory Solid Tumors PHASE2 This is an open-label, single-arm, Phase II investigator-initiated trial of...
Show More Location
The Second Affiliated Hospital of SchoowUniversity
Learn More & Join Trial
Treatment of Abnormal Adipose Tissue Accumulation in Human Immunodeficiency Virus (HIV) Patients PHASE3 The primary objective of the study is to determine if Serostim® 4 mg admini...
Show More Location
University of Alabama/Birmingham
Learn More & Join Trial
Effects of Growth Hormone Administration on Cardiovascular Risk in Cured Acromegalics With Growth Hormone Deficiency NA The purpose of the study is to evaluate the effects of growth hormone (GH) ...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
The Efficacy and Safety of Inpegsomatropin Injection in Children With Short Stature Born Small for Gestational Age PHASE3 This is a multicenter, randomized, open-label, active-controlled Phase III ...
Show More Location
Beijing Children's Hospital, Capital Medical University
Learn More & Join Trial
A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment PHASE2 The purpose of this study in children with Noonan syndrome is to evaluate t...
Show More Location
Childrens Hospital Los Angeles
Learn More & Join Trial
Growth Hormone Replacement in Veterans With GWI and AGHD (GWIT) PHASE2 The goal of the GWIT Study is to assess whether growth hormone replacement ...
Show More Location
Michael E. DeBakey VA Medical Center
Learn More & Join Trial
Long-Acting Growth Hormone in Children Compared to Daily rhGH PHASE3 The trial will compare a twice-monthly somavaratan dosing regimen for non-i...
Show More Location
Multiple Locations
Learn More & Join Trial
An Open-label Phase 4 Study to Explore Immunogenicity of the Liquid Formulation of Saizen® in Subjects With Adult Growth Hormone Deficiency (AGHD) PHASE4 This is an open-label, single-arm, multicenter, Phase 4 study to explore th...
Show More Learn More & Join Trial
Luveris® (Lutropin Alfa for Injection) in Women With Hypogonadotropic Hypogonadism (Luteinizing Hormone [LH] Less Than [<] 1.2 International Unit Per Liter [IU/L]) PHASE4 Sponsor has decided to discontinue Luveris® in the United States (US) due t...
Show More Location
U.S. Medical Information, 1-888-275-7376
Learn More & Join Trial